Skip to content
The Nexus
DossierENTITY

enpatoran

Coverage of enpatoran in the Nexus archive.

Earliest in view: Jun 5 · 17:52 UTCMost recent: Jun 5 · 17:52 UTC
Co-mentioned in this coverage
lupustopic1Toll-like receptor inhibitortopic1MedPage Todayorganization1LONDONplace1
Recent coverage
  • HEALTHJun 5 · 17:52 UTCMEDPAGE TODAY
    Novel Lupus Drugs Continue to Shine in Extended Early Data

    Two investigational lupus drugs demonstrated continued positive results in follow-on studies after showing encouraging primary phase II outcomes. The Toll-like receptor (TLR) inhibitor enpatoran maintained efficacy without diminution in extended data.

enpatoran · Dossier · The Nexus